Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Parsons, AU

Allen Roland Parsons, Western Australia AU

Patent application numberDescriptionPublished
20090104239Method, Material and System for Controlled Release of Anti-Microbial Agents - There is provided a method for treating a fluid with an anti-microbial agent comprising the steps of: (a) contacting the fluid with a solid material containing an anti-microbial agent; and, (b) abrading an interface of the solid material and removing particles therefrom and exposing an underlying surface of the solid material to the fluid, thereby facilitating release of the antimicrobial agent of the underlying surface of the solid material and/or the removed particles into the fluid. The solid material comprises an anti-microbial agent dispersed and/or embedded in a solid carrier. Typically, the anti-microbial agent is one or more of a metal, metal oxide, metal compound, metal salt, metal-ligand complex or derivatives thereof based on silver, copper and zinc.04-23-2009

David Alan Parsons, Melbourne AU

Patent application numberDescriptionPublished
20100156137VEHICLE TONNEAU COVER SYSTEM - A tonneau system for a vehicle bed includes a rail disposed on a top portion of the vehicle bed. A tonneau cover extends over the vehicle bed and includes an elongate retention clip is adjacent the rail and is connected thereto by an interference fit. The elongate retention clip includes a removal tab. A connection clip is slidable along the linear extent of the rail. An elongate band is slidably received in the tonneau cover and in a band aperture of the connection clip.06-24-2010
20100289281REINFORCEMENT TUBE ASSEMBLY - A reinforcement tube assembly for a fastener in a vehicle body structure is provided. The reinforcement tube assembly includes a reinforcement tube and a locator. The locator is affixed to the reinforcement tube. The reinforcement tube is operatively configured to receive a fastener and is operatively configured be installed at least partially within a vehicle body structure. The locator includes at least two mounting surfaces operatively configured to engage with a vehicle body structure. The locator includes at least two mounting surfaces operatively configured to engage with the vehicle body structure.11-18-2010

David Allen Parsons, Diamond Creek AU

Patent application numberDescriptionPublished
20100202850TIE-DOWN DEVICE - The present invention relates to a tie-down device comprising a base member and a retaining member, the retaining member having first and second retaining means suitable to retain the device in a channel, recess or the like, the first retaining means being engageable with a part of the channel or structure associated with the channel, and the second retaining means being engageable with another part of the channel or structure associated with the channel by pushing the retaining member to a distal position away from the base member and twisting the retaining member whilst in the distal position into engagement with the channel or structure associated with the channel.08-12-2010

Jack Gordon Parsons, Victoria AU

Patent application numberDescriptionPublished
20100069393METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME - The present invention relates generally to therapeutic agents, formulations comprising them and their use in the treatment, amelioration and/or prophylaxis of glioma brain tumours and related conditions. The therapeutic agent comprises two fused 6-membered rings with at least a nitrogen at position 1 and a hydroxyl at position 8.03-18-2010
20100144693METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) - The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions.06-10-2010
20110071167METHOD OF TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) - The present invention relates generally to the field of treatment and prophylaxis of retinal degenerative diseases. More particularly, the present invention contemplates a method for preventing, reducing the risk of development of, or otherwise treating or ameliorating the symptoms of, age-related macular degeneration (AMD) or related retinal conditions in mammals and in particular humans. The present invention further provides therapeutic compositions enabling dose-dependent or dose-specific administration of agents useful in the treatment and prophylaxis of age-related macular degeneration or related retinal degenerative conditions.03-24-2011

Matt Goodall Parsons, Victoria AU

Patent application numberDescriptionPublished
20090008338Septic Tanks - A method of determining whether a septic tank containing a liquid and sludge or scum mixture needs to be emptied, comprising locating a sensor in the mixture wherein the sensor is adapted to measure a parameter which can be used to determining the depth of sludge or scum in the septic tank and generating a warning signal when a signal from the sensor is indicative of a depth of sludge or scum exceeding a predetermined limit.01-08-2009

Peter Gordon Parsons, St.lucia AU

Patent application numberDescriptionPublished
20100048698MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C - The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Fuphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.02-25-2010

Peter Gordon Parsons, St. Lucia AU

Patent application numberDescriptionPublished
20110213002MACROCYCLIC DITERPENES FOR TREATING CONDITIONS ASSOCIATED WITH PROTEIN KINASE C - The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species. The present invention further contemplates a method for the prophylaxis or treatment of mammalian, animal or avian subjects for inflammatory conditions including chronic or transitory inflammatory conditions or for ameliorating the symptoms of an inflammatory condition by the topical or systemic administration of a macrocyclic diterpene obtainable from a member of the Euphorbiaceae family or botanical or horticultural relatives thereof or a derivative, chemical analogue or chemically synthetic form of the agent. The chemical agent of the present invention may be in the form of a purified compound, mixture of compounds, a precursor form of one or more of the compounds capable of chemical transformation into a therapeutically active agent or be in the form of a chemical fraction, sub-fraction or preparation or extract of the plant.09-01-2011